MASIMO CORP SEC 10-Q Report

Masimo Corporation, a global leader in innovative noninvasive monitoring technologies, has released its latest Form 10-Q report, showcasing robust financial and operational performance. The report highlights significant growth in revenue and profitability, driven by both healthcare and non-healthcare segments, as well as strategic business decisions that are expected to shape the company's future trajectory. Financial Highlights Masimo Corp reported impressive financial results for the latest quarter, reflecting strong growth and effective cost management:Total Revenue: $370.9 million, up from $343.9 million in the same period last year, driven by growth in both healthcare and non-healthcare segments.Gross Profit: $233.3 million, an increase from $207.3 million, indicating improved cost management and operational efficiency.Operating Income: $64.5 million, compared to $41.9 million, showcasing effective cost control and increased sales.Net Income: $51.3 million, a significant rise from $16.0 million, primarily due to higher revenue and better cost management.Basic Income Per Share: $0.95, up from $0.30, reflecting the company's strong financial performance and profitability.Diluted Income Per Share: $0.94, compared to $0.30, indicating enhanced earnings per share due to increased net income. Business Highlights Masimo Corp's operational performance was marked by several key highlights:Revenue Segments: The company operates two reportable segments: healthcare and non-healthcare. The healthcare segment includes patient monitoring solutions sold to hospitals, emergency medical service providers, and other healthcare facilities. The non-healthcare segment, which was classified as held-for-sale, includes consumer audio and home integration technologies.Geographical Performance: Masimo has a significant international presence, with operations in North and South America, Europe, the Middle East, and Asia-Pacific regions. The functional currency for the international headquarters in Switzerland is the U.S. Dollar, indicating a focus on maintaining consistency in financial reporting across regions.Sales Units: The company derives revenue from direct sales under deferred equipment agreements, sales to distributors, and sales of integrated circuit boards to OEM customers. These sales are made on open accounts with industry-standard payment terms based on the customer's geography.Future Outlook: Masimo is in the process of selling its non-healthcare business to Harman International Industries, a subsidiary of Samsung Electronics. This strategic move is expected to impact future operations and allow the company to focus more on the healthcare segment. Additionally, the fiscal year 2025 is a 53-week fiscal year, which may affect the comparability of financial results.SEC Filing: MASIMO CORP [ MASI ] - 10-Q - Aug. 05, 2025